TD Waterhouse Canada’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
ACA
DCM
JT
TD Waterhouse Canada's DFTX Position: Q2 2026 in Review
TD Waterhouse Canada increased its Definium Therapeutics (DFTX) stake by 1,936% in Q2 2026, buying an estimated $862K and bringing the position to 36,694 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #625.
TD Waterhouse Canada first reported a position in DFTX in Q4 2021 and has held it in 19 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.
- TD Waterhouse Canada held 36,694 shares of Definium Therapeutics worth $1.59M as of Q2 2026.
- TD Waterhouse Canada bought 34,892 Definium Therapeutics shares in Q2 2026, an estimated $862K.
- Definium Therapeutics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #625 holding.
- TD Waterhouse Canada first reported a position in Definium Therapeutics in Q4 2021 and has held it in 19 quarters since.
- 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.
Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.